Darren S. Cline

Insider Reports History

Entity
Individual
Location
35 Cambridge Park Drive, Cambridge, Massachusetts
Signature
/s/ Mike Ouimette, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Darren S. Cline:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pyxis Oncology, Inc. Director Common Stock 251K $352K $1.40 Mar 26, 2024 Direct
PLIANT THERAPEUTICS, INC. Director Common Stock (Right to Buy) 26.8K $55.7K $2.08 Jun 13, 2024 Direct
IMPEL PHARMACEUTICALS INC Director Stock Option (right to buy) 13.2K Jun 16, 2023 Direct
GW PHARMACEUTICALS PLC U.S. Chief Commercial Officer Ordinary Shares 0 May 5, 2021 Direct
GW PHARMACEUTICALS PLC U.S. Chief Commercial Officer Share Options 0 May 5, 2021 Direct

Insider Reports Filed by Darren S. Cline

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLRX PLIANT THERAPEUTICS, INC. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
PYXS Pyxis Oncology, Inc. Mar 26, 2024 1 $0 4 Mar 28, 2024 Director
IMPL IMPEL PHARMACEUTICALS INC Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
IMPL IMPEL PHARMACEUTICALS INC Apr 12, 2023 1 $0 4 Apr 14, 2023 Director
IMPL IMPEL PHARMACEUTICALS INC Apr 12, 2023 0 $0 3 Apr 13, 2023 Director
PYXS Pyxis Oncology, Inc. Mar 24, 2023 1 $0 4 Mar 28, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Mar 6, 2023 1 $0 4 Mar 8, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Mar 6, 2023 0 $0 3 Mar 8, 2023 Director
PYXS Pyxis Oncology, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
PYXS Pyxis Oncology, Inc. Dec 8, 2021 1 $93.9K 4 Dec 9, 2021 Director
PYXS Pyxis Oncology, Inc. Oct 7, 2021 1 $0 4 Oct 12, 2021 Director
PYXS Pyxis Oncology, Inc. Oct 7, 2021 0 $0 3 Oct 7, 2021 Director
GWPH GW PHARMACEUTICALS PLC May 5, 2021 8 $0 4 May 7, 2021 U.S. Chief Commercial Officer